Literature DB >> 3258058

Mutagenicity monitoring in humans by autoradiographic assay for mutant T lymphocytes.

R J Albertini1, L M Sullivan, J K Berman, C J Greene, J A Stewart, J M Silveira, J P O'Neill.   

Abstract

Somatic cell mutation which occurs in vivo in humans can be determined by measurement of the frequency of the 6-thioguanine-resistant (TGr) T lymphocytes in samples of peripheral blood. This frequency can be determined by either a short-term autoradiographic methodology or a longer cell-cloning methodology. The advantage of the former is the relative simplicity of the assay, while the latter allows recovery of mutant clones for further characterization. This report presents results of a longitudinal study of cancer chemotherapy nurses and other health care personnel by use of the autoradiography assay. The use of this assay in human mutagenicity monitoring and the analysis of the TGr cell frequencies are discussed in terms of age effects and validation of 'elevated' frequencies by use of the clonal assay. This report then presents evidence that both assays yield similar TGr cell frequencies in two groups of 'normal adults'. The mean variant frequency (+/- S.D.) for 82 autoradiographic assays was 8.7 (+/- 6.1) X 10(-6), while the mean mutant frequency (+/- S.D.) for 115 clonal assays was 6.5 (+/- 4.8) X 10(-6). In addition, concurrent autoradiographic and clonal assays on 33 individuals yielded mean values (+/- S.D.) of 8.4 (+/- 8.5) X 10(-6) and 10.5 (+/- 6.3) X 10(-6), respectively.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3258058     DOI: 10.1016/0165-1218(88)90043-2

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  10 in total

1.  Influence of sex, smoking and age on human hprt mutation frequencies and spectra.

Authors:  J Curry; L Karnaoukhova; G C Guenette; B W Glickman
Journal:  Genetics       Date:  1999-07       Impact factor: 4.562

2.  Evaluation of genotoxic risk of handling cytostatic drugs in clinical pharmacy practice.

Authors:  E P Guinée; G H Beuman; G Hageman; I J Welle; J C Kleinjans
Journal:  Pharm Weekbl Sci       Date:  1991-04-26

3.  Fine structure mapping of the hypoxanthine-guanine phosphoribosyltransferase (HPRT) gene region of the human X chromosome (Xq26).

Authors:  J A Nicklas; T C Hunter; J P O'Neill; R J Albertini
Journal:  Am J Hum Genet       Date:  1991-08       Impact factor: 11.025

4.  Mutagenic activity of BKV and JCV in human and other mammalian cells.

Authors:  M Theile; G Grabowski
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

5.  Molecular analyses of a Lesch-Nyhan syndrome mutation (hprtMontreal) by use of T-lymphocyte cultures.

Authors:  T R Skopek; L Recio; D Simpson; L Dallaire; S B Melancon; H Ogier; J P O'Neill; M T Falta; J A Nicklas; R J Albertini
Journal:  Hum Genet       Date:  1990-06       Impact factor: 4.132

Review 6.  In vivo mutations in human blood cells: biomarkers for molecular epidemiology.

Authors:  R J Albertini; J A Nicklas; J C Fuscoe; T R Skopek; R F Branda; J P O'Neill
Journal:  Environ Health Perspect       Date:  1993-03       Impact factor: 9.031

7.  hprt mutant lymphocyte frequencies in workers at a 1,3-butadiene production plant.

Authors:  J B Ward; M M Ammenheuser; W E Bechtold; E B Whorton; M S Legator
Journal:  Environ Health Perspect       Date:  1994-11       Impact factor: 9.031

8.  Mutagenesis after cancer therapy.

Authors:  K T Kelsey; M Caggana; P M Mauch; C N Coleman; J R Clark; H L Liber
Journal:  Environ Health Perspect       Date:  1993-10       Impact factor: 9.031

Review 9.  Human somatic mutation assays as biomarkers of carcinogenesis.

Authors:  P J Compton; K Hooper; M T Smith
Journal:  Environ Health Perspect       Date:  1991-08       Impact factor: 9.031

10.  Somatic cell gene mutations in humans: biomarkers for genotoxicity.

Authors:  R J Albertini; J A Nicklas; J P O'Neill
Journal:  Environ Health Perspect       Date:  1993-10       Impact factor: 9.031

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.